LDOS

Leidos

$129.35

+0.09%
Sep 16, 2026
Bobby Quantitative Model
Leidos Holdings, Inc. is a technology, engineering, and science company that delivers services and solutions across defense, intelligence, civil, and health end-markets, primarily serving U.S. government customers including the Department of Defense, the Intelligence Community, DHS, the FAA, and the VA through four reportable segments: National Security & Digital, Health & Civil, Commercial & International, and Defense Systems. With roughly 47,000 employees and a market capitalization near $24 billion, Leidos is one of the largest pure-play government services and IT contractors in the United States, distinguished by its scale, security clearances, and incumbency on long-cycle federal programs rather than by proprietary product IP. The current investor narrative is dominated by a sharp de-rating: shares have fallen roughly 30% over the past year and nearly 30% year-to-date, driven by a February 2026 earnings reaction in which record profits were overshadowed by a revenue miss, cautious guidance, and government shutdown-related uncertainty, compounded by competitive anxiety over private disruptors such as Saronic in autonomous naval systems. Bulls point to a depressed forward multiple near 10x, a stable dividend, and a $1.86 billion trailing free cash flow base as evidence the selloff is overdone, while bears question whether federal budget pressure, program recompetes, and procurement shifts toward cheaper autonomous platforms structurally cap growth for legacy services primes.

People also watch

IBM

IBM

IBM

Analysis
Accenture

Accenture

ACN

Analysis
Cognizant Technology Solutions

Cognizant Technology Solutions

CTSH

Analysis
Fiserv

Fiserv

FISV

Analysis
Fidelity National Information Services

Fidelity National Information Services

FIS

Analysis

BobbyInvestment Opinion: Should I buy LDOS Today?

The synthesized recommendation is a Hold with a bullish bias for value-oriented investors. The core thesis is that Leidos is a high-quality government services franchise trading at a deep discount—10.1x forward earnings and 1.41x sales—with a $156.60 average analyst target implying 21.5% upside, but near-term revenue growth of 3.65% and margin compression warrant caution until a turnaround is confirmed. The analyst consensus rating is 'buy' (mean 2.35), but the stock's 30% one-year decline and -46.6% relative underperformance suggest the market is pricing in structural headwinds.

Supporting evidence for a constructive view includes: (1) a forward PE of 10.1x, which is well below the S&P 500's average and the company's own historical multiple; (2) a PEG ratio of 0.82, indicating the stock is cheap relative to expected earnings growth; (3) robust free cash flow of $1.86 billion TTM, which supports the dividend (0.87% yield) and potential buybacks; and (4) a net margin of 8.48% and ROE of 29.6%, demonstrating underlying profitability. The implied upside to the average analyst target is 21.5%, and even the low target of $125 is only 3% below the current price, suggesting limited downside according to the sell-side.

Key risks that could invalidate the thesis include: (1) a sustained revenue decline if government budgets tighten or program recompetes are lost; (2) further margin erosion from competitive pricing pressure; and (3) competitive disruption from private autonomous defense firms. The rating would upgrade to Buy if revenue growth accelerates above 5% and gross margins stabilize above 18%, or downgrade to Sell if revenue growth turns negative or if the forward PE fails to hold above 9x. Relative to its history and peers, LDOS appears undervalued, but the market is demanding evidence that the growth slowdown is temporary.

Sign up to view all

LDOS 12-Month Price Forecast

Leidos presents a classic value-versus-growth trap debate. The stock is statistically cheap at 10.1x forward earnings with a PEG of 0.82, and the analyst consensus target implies meaningful upside. However, the revenue growth slowdown to 3.65% and margin compression suggest the discount may be warranted until proven otherwise. The low beta and stable free cash flow make it a defensive holding, but competitive threats from private autonomous defense firms could cap long-term growth. I would upgrade to bullish if revenue growth reaccelerates above 5% and gross margins stabilize, and downgrade to bearish if revenue turns negative or if the company loses a major recompete.

Historical Price
Current Price $129.35
Average Target $155.00
High Target $225.00
Low Target $98.00

Wall Street consensus

Most Wall Street analysts maintain a constructive view on Leidos's 12-month outlook, with a consensus price target around $156.60 and implied upside of +21.1% versus the current price.

Average Target

$156.60

0 analysts

Implied Upside

+21.1%

vs. current price

Analyst Count

covering this stock

Price Range

$125 - $225

Analyst target range

Drowning in data?

Find the real signal!

Bulls vs Bears: LDOS Investment Factors

The bear case currently has stronger near-term evidence: LDOS has lost nearly a third of its value over the past year, revenue growth has decelerated to 3.65%, and gross margins are compressing. However, the bull case rests on compelling valuation support—10.1x forward earnings, a PEG of 0.82, and a $156.60 average analyst target implying 21.5% upside—along with a low beta and robust free cash flow. The single most important tension is whether the revenue slowdown is a cyclical pause tied to government shutdown uncertainty or the beginning of a structural decline driven by procurement shifts toward autonomous systems and private competitors. If revenue growth reaccelerates above 5% and margins stabilize, the stock is deeply undervalued; if growth turns negative, the forward multiple could prove to be a value trap.

Bullish

  • Deeply discounted forward multiple: LDOS trades at just 10.1x forward earnings (pe_forward 10.106) and 1.41x sales (ps_ratio 1.4145), a steep discount to the broader technology sector and its own historical range. The PEG ratio of 0.82 (below 1.0) suggests the market is pricing in far worse growth than the company is actually delivering.
  • Analyst consensus sees 21.5% upside: 15 analysts rate the stock a 'buy' with an average target price of $156.60 versus the current $128.86, implying 21.5% upside. Even the lowest analyst target of $125.00 is only 3% below the current price, suggesting limited downside from here according to the sell-side.
  • Strong profitability and cash generation: Net margin stands at 8.48% and operating margin at 12.27%, while trailing free cash flow is $1.86 billion. Return on equity is a robust 29.6%, indicating the business remains highly profitable despite the revenue growth slowdown.
  • Low beta defensive profile: With a beta of just 0.572, LDOS is significantly less volatile than the broader market, making it a defensive holding in uncertain macro environments. The dividend yield of 0.87% is modest but backed by a conservative 14.5% payout ratio, leaving ample room for growth or buybacks.

Bearish

  • Severe relative underperformance: LDOS has fallen 30.4% over the past year and 29.8% year-to-date, massively underperforming the S&P 500's +16.2% and +12.1% respective returns. Relative strength versus the SPY is -46.6% over one year, indicating persistent institutional selling pressure.
  • Revenue growth decelerating sharply: Q1 2026 revenue growth of 3.65% YoY is a marked slowdown from prior periods, and the February 2026 earnings report featured a revenue miss alongside cautious guidance. Government shutdown uncertainty and program recompetes threaten to further pressure top-line growth.
  • Margin compression evident: Gross margin has declined from 18.4% in Q2 2025 to 17.3% in Q1 2026, and net margin fell to 7.45% in Q1 2026 from 9.19% in Q2 2025. The trend suggests pricing pressure and mix shift toward lower-margin work.
  • Competitive disruption from private players: Private companies like Saronic are rapidly advancing in autonomous naval systems, potentially disrupting traditional defense procurement. The Navy's pivot to cheaper autonomous vessels could structurally reduce demand for legacy services primes like Leidos.

LDOS Technical Analysis

Beta

0.57

0.57x market volatility

Max Drawdown

-49.9%

Largest decline past year

52-Week Range

$99-$206

Price range past year

Annual Return

-29.2%

Cumulative gain past year

PeriodLDOS ReturnS&P 500
1m-9.1%-2.4%
3m+20.8%+1.0%
6m-22.0%+16.3%
1y-29.2%+14.3%
ytd-29.5%+10.6%

Bobby - Your AI Investment Partner

Get real-time data, AI-driven personalized investment analysis to make smarter investment decisions

LDOS Fundamental Analysis

Quarterly Revenue

$4.4B

2026-04

Revenue YoY Growth

+3.6%

YoY Comparison

Gross Margin

17.3%

Latest Quarter

Free Cash Flow

$1.9B

Last 12 Months

Revenue & Net Income Trends (2 Years)

Revenue Breakdown

Health Segment

Open an Account, get $2 TSLA now!

Valuation Analysis: Is LDOS Overvalued?

PE

16.4x

Latest Quarter

vs. Historical

Mid-Range

5-Year PE Range 12x~21x

vs. Industry Avg

N/A

Industry PE ~N/A*

EV/EBITDA

12.1x

Enterprise Value Multiple

Investment Risk Disclosure

Financial and operational risks are significant. Leidos carries a debt-to-equity ratio of 1.21, which is high for a government services firm and exposes it to interest rate risk; interest expense was $55 million in Q1 2026 alone. Gross margin has compressed from 18.4% in Q2 2025 to 17.3% in Q1 2026, and net margin fell to 7.45% from 9.19% over the same period, indicating pricing pressure and unfavorable mix. Revenue growth has slowed to just 3.65% year-over-year in Q1 2026, and the company's heavy reliance on U.S. government contracts—particularly from the DoD and Intelligence Community—concentrates risk in a single customer that is subject to budget cycles and shutdowns. Additionally, the trailing EPS of $0.06 (likely distorted by one-time items) contrasts sharply with the quarterly EPS of $2.60, highlighting earnings volatility.

Market and competitive risks are mounting. The stock trades at a forward PE of 10.1x, which is low relative to the broader market but may reflect structural concerns rather than a temporary discount. With a beta of 0.572, LDOS is less sensitive to market swings, but its -46.6% relative underperformance versus the S&P 500 over the past year shows it is not immune to sector rotation away from government services. Private disruptors like Saronic, which is developing autonomous naval vessels, threaten to take share in defense procurement as the Navy pivots to cheaper, faster platforms. Regulatory headwinds, including potential budget cuts and shifting procurement priorities, could further pressure revenue. The recent news of a government shutdown and weak outlook overshadowing record profits underscores the market's focus on forward risks.

In a worst-case scenario, a prolonged government shutdown or budget sequestration could delay contract awards, causing revenue to decline and margins to compress further. If revenue growth turns negative and the forward PE contracts to 8x on lower earnings, the stock could retest its 52-week low of $98.86, representing a 23.3% decline from the current price of $128.86. The analyst low target of $125.00 is only 3% below current levels, but in a severe downturn, the stock could overshoot to the downside given its max drawdown of -49.89% from prior highs. Investors could lose 23% to 30% from current levels in this adverse scenario, with the possibility of a deeper decline if competitive threats accelerate.

FAQ

The most severe risk is revenue concentration in U.S. government contracts, which exposes Leidos to budget cuts, shutdowns, and procurement shifts—Q1 2026 revenue growth was just 3.65%, and a government shutdown already pressured guidance in February 2026. Second, competitive disruption from private firms like Saronic in autonomous naval systems could structurally reduce demand for legacy services, as the Navy pivots to cheaper platforms. Third, margin compression is evident: gross margin fell from 18.4% in Q2 2025 to 17.3% in Q1 2026, and net margin declined to 7.45%. Fourth, the high debt-to-equity ratio of 1.21 increases financial risk, especially if interest rates remain elevated. Ranked by severity: revenue concentration and competitive disruption are the most critical, followed by margin pressure and leverage.

Our 12-month forecast has three scenarios: a base case (55% probability) with a target range of $145-$165, assuming revenue growth stabilizes at 4-5% and the stock trades toward the analyst average of $156.60; a bull case (25% probability) targeting $180-$225 if government budgets resolve favorably and revenue growth reaccelerates above 5%, driving multiple expansion; and a bear case (20% probability) targeting $98-$125 if a prolonged shutdown or major recompete loss occurs, retesting the 52-week low. The most likely scenario is the base case, which assumes no major budget disruption and gradual improvement in growth. The key assumption is that the current revenue slowdown is cyclical, not structural, and that Leidos maintains its incumbency on major contracts.

LDOS appears undervalued on most metrics. The forward PE of 10.1x is significantly below the S&P 500's average of roughly 20x and below its own historical range, while the PS ratio of 1.41x and EV/EBITDA of 12.1x are also modest. The PEG ratio of 0.82 (below 1.0) indicates the stock is cheap relative to expected earnings growth. However, the market is pricing in structural concerns: revenue growth of 3.65% is anemic, and the 30% one-year decline reflects fears that government services spending may be peaking. Compared to peers in the IT services sector, LDOS trades at a discount, but that discount may be justified until growth stabilizes. The valuation implies the market expects low single-digit growth and margin pressure to persist.

From a risk/reward perspective, LDOS offers a compelling value proposition with 21.5% upside to the average analyst target of $156.60, but it comes with significant near-term uncertainty. The stock trades at just 10.1x forward earnings and 1.41x sales, well below market averages, and has a PEG ratio of 0.82, suggesting it is cheap relative to growth. However, revenue growth has slowed to 3.65% and gross margins are compressing, which explains the discount. The biggest downside risk is a retest of the 52-week low of $98.86, representing 23% downside, if government budgets tighten or competitive threats materialize. For value-oriented investors with a 12-18 month horizon, the risk/reward is favorable, but conservative investors may want to wait for evidence of revenue reacceleration before buying.

LDOS is better suited for long-term investment (minimum 12-18 months) than short-term trading. The stock has a low beta of 0.572, indicating lower volatility than the market, but it has experienced a max drawdown of -49.89% and a 30% one-year decline, so short-term trading carries significant timing risk. The dividend yield of 0.87% is modest but stable, with a conservative 14.5% payout ratio, making it an income compounder over time. Earnings visibility is moderate given government contract cycles, but the company's $1.86 billion free cash flow and 29.6% ROE support a long-term holding thesis. A suggested minimum holding period is 12-18 months to allow for resolution of budget uncertainty and potential multiple re-rating. Short-term traders should note the stock's recent 3-month gain of 5.48% but be wary of earnings-related volatility.